Pivotal-Point Tracking Becton Dickinson: Piper Sandler Raises Price Target to $200 Following Strong 3rd Quarter!

Becton Dickinson is engaged in the development, manufacturing, and distribution of medical devices, laboratory equipment, and diagnostic products. With over 70,000 employees and a presence in more than 190 countries, the company plays a pivotal role in improving healthcare. On August 7, 2025, Becton Dickinson reported its results for the 3rd quarter of 2025. The company exceeded expectations, achieving revenue of $5.5 billion, representing a 10.4% increase compared to the previous year. The adjusted earnings per share were $3.68. Management highlighted...